On Illumina and the cost per genome
|Aug 23, 2014|
I recall being a somewhat younger investor looking at ideas a decade ago and Illumina seemed pie-in-the-sky, and was stock that traded in the low digits at one time. I traded it and have regretted ever since, for having sold those shares long ago. Secular trends, like all worthy speculative ventures, take time to foster and nurture into maturity, including: marriage, fixer-upper first homes, salvaging a debt-laden balance sheet (for nations and individuals alike), and not just new industries.